FES-assisted Gait Intervention in People With Spinal Cord Injury - Pilot Study

Sponsor
Stichting Reade (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05908175
Collaborator
(none)
5
1
1
19.8
0.3

Study Details

Study Description

Brief Summary

A spinal cord injury (SCI) disrupts the communication within the nervous system, leading to limitations in sensorimotor activities such as walking. Regular use of functional electrical stimulation (FES) can result in recovery of voluntary muscle control and muscle strength. Locomotor training with FES may be a promising method to improve gait function. The primary objective of this pilot study is to assess the feasibility and safety of an FES-assisted gait training intervention. Secondary objectives are to assess the effects of an FES-assisted gait training intervention on gait function.

Condition or Disease Intervention/Treatment Phase
  • Other: FES-assisted gait training
N/A

Detailed Description

A spinal cord injury (SCI) disrupts the communication within the nervous system, leading to limitations in sensorimotor activities, such as walking. These limitations are associated with muscle weakness, a disturbance of the reflex activity, and the inability or difficulty to recruit muscles below the lesion. Regular use of functional electrical stimulation (FES) can result in recovery of voluntary muscle control and muscle strength. Studies that investigated the effect of locomotor training on a treadmill with functional electrical stimulation and/or body weight support (BWS) show improved function of the lower limbs. FES-assisted gait therapy may be a promising method for improving gait function in individuals with an incomplete SCI. Therefore, this study will investigate if an FES-assisted gait (with BWS) is feasible and safe. This study will also investigfate if an FES-assisted gait can improve gait function in people with an incomplete SCI.

Primary objective of this pilot study is to assess the feasibility and safety of an FES-assisted gait training intervention. The secondary objectives are to assess the effects of an FES-assisted gait training intervention on gait function.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
5 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Pilot StudyPilot Study
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
FES-assisted Gait Training Intervention to Improve Gait in Individuals With an Incomplete Spinal Cord Injury - a Pilot Study
Actual Study Start Date :
May 10, 2023
Anticipated Primary Completion Date :
Jan 1, 2025
Anticipated Study Completion Date :
Jan 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Other: Intervention group

FES-assisted gait training intervention group

Other: FES-assisted gait training
The participants will walk with functional electrical stimulation (and possible body weight support) on a treadmill for 10 weeks, twice a week for 30 minutes.

Outcome Measures

Primary Outcome Measures

  1. Feasibility of the intervention [Assessed during week 11 during the post-intervention measurement.]

    Self-administered questionnaires about the training sessions, preceived effect, applicability of FES and the experience with walking with FES.

  2. Incidence of (Serious) Adverse Events [Safety of the Intervention] [Assessed during week 1 to 10 for each FES-assisted gait training session (2x week) and in week 0, week 11 and week 21 (during the pre-, post- and follow-up measurements)]

    The total number of (serious) adverse events

Secondary Outcome Measures

  1. Change in average and maximum treadmill walking speed [Assessed during each FES-assisted gait training session (from week 1 until week 10, 2x a week)]

    Average and maximum walking speed (m/s) recorded by the treadmill during each training session

  2. Change in distance [Assessed during each FES-assisted gait training session (from week 1 until week 10, 2x a week)]

    Distance (in meters) recorded by the treadmill during each training session.

  3. Change in average overground walking speed [Assessed before and after the 10-weeks FES-assisted gait training intervention (during week 0 and week 11)]

    Walking speed (m/s) measured by 10 meter walk test

  4. Change in muscle activity [Assessed before and after the 10-weeks FES-assisted gait training intervention (during week 0 and week 11)]

    Surface EMG measurement during 10 meter walk test. Time of muscle activation and duration of muscle activity of the m. rectus femoris, m. vastus lateralis, m. semitendinosus, m. tibialis anterior, m. gastrocnemius medialis, m. soleus and m. peroneus longus

  5. Change in step length [Assessed before and after the 10-weeks FES-assisted gait training intervention (during week 0 and week 11)]

    Step length left and right (cm) measured during 10 meter walk test with the interactive walkway (kinect)

  6. Change in step width [Assessed before and after the 10-weeks FES-assisted gait training intervention (during week 0 and week 11)]

    Step width (cm) measured during 10 meter walk test with interactive walkway (kinect)

  7. Change in cadence [Assessed before and after the 10-weeks FES-assisted gait training intervention (during week 0 and week 11)]

    Cadence (steps/min) measured during 10 meter walk test with interactive walkway (kinect)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Have a non-progressive incomplete SCI.

  • Have limited motor abilities in the lower extremities.

  • Be able to walk on a treadmill for 30 minutes (with body weight support).

  • Be able to perform the 10 meter walk test overground with assistive devices and/or support form the researcher/physician.

  • Have a stable medical condition.

  • Have had the SCI for at least a year.

  • Be at least 18 years of age.

Exclusion Criteria:
  • Cardiac arrhythmias or cardiac disease;

  • Flaccid paralysis.

  • Musculoskeletal dysfunction, uncured fractures, contractures, pressure injuries, or infections that could impede the intended training;

  • A history of severe autonomic dysreflexia assessed with the 'Autonomic standards assessment';

  • Neurostimulator, pacemaker, or other device that prevents the safe use of electrical stimulation present in the body;

  • Very high sensitivity to electrical stimulation, i.e., sensitivity threshold is reached before motor responses are observed in all target muscles;

  • Insufficient mastery of the Dutch language (speaking and reading);

  • Severe cognitive or communicative disorders;

  • Being or becoming pregnant during the study period;

  • Severe psychiatric illness or disorders (at the discretion of the treating rehabilitation physician);

  • Involved in another intervention study which may have an effect on the outcome measures of the present study;

Contacts and Locations

Locations

Site City State Country Postal Code
1 Stichting Reade Amsterdam Netherlands 1054HW

Sponsors and Collaborators

  • Stichting Reade

Investigators

  • Principal Investigator: Thomas Janssen, Prof. Dr., Stichting Reade

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Stichting Reade
ClinicalTrials.gov Identifier:
NCT05908175
Other Study ID Numbers:
  • W23.009
  • NL82880.015.22
First Posted:
Jun 18, 2023
Last Update Posted:
Jun 18, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 18, 2023